Details for Patent: 7,790,755
✉ Email this page to a colleague
Which drugs does patent 7,790,755 protect, and when does it expire?
Patent 7,790,755 protects DEXILANT and is included in one NDA.
Protection for DEXILANT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-one patent family members in twenty-nine countries.
Summary for Patent: 7,790,755
Title: | Controlled release preparation |
Abstract: | A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient. |
Inventor(s): | Akiyama; Yohko (Osaka, JP), Kurasawa; Takashi (Osaka, JP), Bando; Hiroto (Osaka, JP), Nagahara; Naoki (Osaka, JP) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Application Number: | 10/531,069 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,790,755 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Formulation; |
Drugs Protected by US Patent 7,790,755
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,790,755
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2002-301876 | Oct 16, 2002 |
Japan | 2003-066336 | Mar 12, 2003 |
PCT Information | |||
PCT Filed | October 15, 2003 | PCT Application Number: | PCT/JP03/13155 |
PCT Publication Date: | April 29, 2004 | PCT Publication Number: | WO2004/035020 |
International Family Members for US Patent 7,790,755
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 041562 | ⤷ Try a Trial | |||
Argentina | 103296 | ⤷ Try a Trial | |||
Australia | 2003272098 | ⤷ Try a Trial | |||
Australia | 2009243408 | ⤷ Try a Trial | |||
Brazil | 0315142 | ⤷ Try a Trial | |||
Brazil | 122016030094 | ⤷ Try a Trial | |||
Brazil | PI0315142 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |